References
- Agilli M, Aydin FN, Cayci T, Kurt YG. Value of pentraxin3 (PTX3) in patients with neovascular age-related macular degeneration. Ocul Immunol Inflamm. 2016;24:358.
- Min JK, Kim J, Woo JM. Elevated plasma pentraxin3 levels and its association with neovascular age-related macular degeneration. Ocul Immunol Inflamm. 2015;23:205--211.
- Yang HS, Woo JE, Lee SJ, et al. Elevated plasma pentraxin3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type II DM. Invest Ophthalmol Vis Sci. 2014;55:5989--5997